User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

January 2, 2026

Study Completion Date

January 2, 2026

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DEVICE

DuraTouch®

Participants will subcutaneously inject the insulin using DuraTouch®.

Trial Locations (11)

50-414

RECRUITING

Ginemedica Sp. z o.o. Sp.k, Wroclaw

31-530

RECRUITING

CenterMed Krakow Sp. z o.o., Krakow

59-300

RECRUITING

Diabetolog praktyka lekarska - Bartosz Bednarkiewicz, Lubin

20-718

RECRUITING

Centrum Medyczne Ekamed sp. z o.o., Lublin

65-034

RECRUITING

Gabinet Lekarski Internistyczny Iwona Towpik, Zielona Góra

02-507

RECRUITING

Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji - Klinika Chorob Wewnetrznych, Endokrynologii i Diab, Warsaw

48-300

RECRUITING

Diabetica sp. z o.o., Nysa

15-404

RECRUITING

Poradnia Diabetologiczna. Niepubliczny Zaklad Opieki Zdrowotnej Lege Artis, Bialystok

80-858

RECRUITING

NZOZ Gdanska Poradnia Cukrzycowa Sp. z o.o, Gdansk

90-302

RECRUITING

"Santa Familia PTG tódz", Lodz

41-500

RECRUITING

Diab Serwis POPENDA Spólka Jawna, Chorzów

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY